Rocuronium Bromide Injection, Solution
Product Images NDC 71839-142

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 71839-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Be Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Rocuro100mgcarton)

FDA Label Image

Vial (Rocuro100mgviallabel)

Vial (Rocuro100mgviallabel)
This text appears to be a description of a medication called Rocuronium Bromide Injection. It is indicated for intravenous use only and comes in a 10 mL multiple-dose vial with a concentration of 100 mg/10 mL (10 mg/mL). The text includes warnings about the medication being a paralyzing agent, emphasizing the need for facilities with artificial respiration support to be immediately available. Storage instructions specify that the medication should be stored in a refrigerator at a temperature of 2° to 8°C (36° to 46°F) and should not be frozen. Once removed from refrigeration, it should be used within 60 days. Opened vials should be used within 30 days. The medication is manufactured by Caplin Steriles Limited in India and distributed by BE Pharmaceuticals Inc. located at 203 New Edition Court Cary, NC 27511. Unfortunately, the expiration date is not readable from the provided text.*
FDA Label Image

Carton (Rocuro50mgcarton)

FDA Label Image

Vial (Rocuro50mgviallabel)

Vial (Rocuro50mgviallabel)
This text provides information about a medication called Rocuronium Bromide Injection. It is a paralyzing agent used for intravenous use only. The medication is available in a 5 mL multiple-dose vial and contains 50 mg of Rocuronium Bromide per 5 mL (equivalent to 10 mg/mL). It is sterile and nonpyrogenic. The warning on the label emphasizes that the medication can cause respiratory arrest and facilities must have artificial respiration readily available. The storage instructions indicate that it should be stored in a refrigerator between 2° to 8°C (36° to 46°F) and should not be frozen. If removed from refrigeration, it can be stored at room temperature (25°C/77°F) for up to 60 days. Opened vials should be used within 30 days. The medication is manufactured by Caplin Steriles Limited in India and distributed by BE Pharmaceuticals Inc. in Cary, NC. The text also includes a batch number, lot number, and expiration date, but these details are not readable in the provided text.*
FDA Label Image

Figure1 (Rocurofigure1)

FDA Label Image

Figure2 (Rocurofigure2)

FDA Label Image

Figure3 (Rocurofigure3)

FDA Label Image

Structure (Rocurostrucaplin)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.